Clinical Trial Update: Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing risperidone versus olanzapine as add-on therapy in treatment-resistant major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• RISPERIDONE (RISPERIDONE)
• olanzapine (olanzapine)

Snippet

Sponsor: Sunnybrook Health Sciences Centre | Conditions: Subjects Had Unipolar, Non-psychotic Major Depression | Phase 1, Phase 2 | Status: COMPLETED